Oxybutynin Chloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Oxybutynin Chloride
Europe

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Oxybutynin Chloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 13 USDMF, 10 CEP/COS, 3 JDMF, 2 EU WC, 1 KDMF, 11 NDC API, 10 Listed Suppliers, $ API Reference Price

24 API Suppliers
13 USDMF
10 CEP/COS
3 JDMF
2 EU WC
1 KDMF
11 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

94 FDF Dossiers, 61 FDA Orange Book, 12 Europe, 10 Canada, 5 South Africa, 6 Listed Dossiers

94 FDF Dossiers
61 FDA Orange Book
12 Europe
10 Canada
5 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik, 2 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 5 DKSH, 2 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 64 Coating Systems & Additives, 45 Direct Compression, 42 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 28 Granulation, 28 Solubilizers, 27 Taste Masking, 26 Thickeners and Stabilizers, 26 Film Formers & Plasticizers, 25 Parenteral, 25 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Topical, 16 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 7 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

90 Fillers, Diluents & Binders
64 Coating Systems & Additives
45 Direct Compression
42 Controlled & Modified Release
30 Disintegrants & Superdisintegrants
28 Granulation
28 Solubilizers
27 Taste Masking
26 Thickeners and Stabilizers
26 Film Formers & Plasticizers
25 Parenteral
25 Lubricants & Glidants
19 Co-Processed Excipients
17 Topical
16 Chewable & Orodispersible Aids
10 Emulsifying Agents
7 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

17 NEWS #PharmaBuzz

17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 13 Finished Drug Prices

2 US Medicaid Prescriptions
13 Finished Drug Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 8 Health Canada Patents

3 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 653 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

12 All

01 1Sanofi AB

02 2Accord Healthcare Ltd.

03 1EG SPA

04 3Janssen-Cilag AB

05 1MYLAN SPA

06 1Melisana AG

07 1Mylan AB

08 2Nicobrand Limited

filter Active Ingredients Reset all filters

12 All

01 2Oxybutynin hydrochloride

02 1Oxybutynin hydrochlorideum

03 9oxibutyninhydroklorid

filter Dosage Form Reset all filters

12 All

01 1GEL DOSING PUMP

02 1GEL IN SACHET

03 1L?s

04 3PROLONGED-RELEASE TABLET

05 1TABLET

06 3TABLETT

07 1Tablet

08 1Tablets

filter Country Reset all filters

12 All

01 2Italy

02 9Sweden

03 1Switzerland

filter Brand Name Reset all filters

12 All

01 1Ditropan

02 2Kentera

03 3Lyrinel

04 1OXYBUTYN EG

05 1OXYBUTYN HYDROCHLORIDE MYLAN GENERICS

06 2Oxybutynin Accord

07 1Oxybutynin Mylan

08 1Vesoxx

List of Suppliers

Product Main Page

01

Sanofi AB

2024 ACI Convention

Not Confirmed

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Ditropan

Dosage Form : TABLET

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

02

Accord Healthcare Ltd.

2024 ACI Convention

Not Confirmed

Accord Healthcare Ltd.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Oxybutynin Accord

Dosage Form : TABLETT

Dosage Strength : 2,5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Accord Healthcare Ltd.

2024 ACI Convention

Not Confirmed

Accord Healthcare Ltd.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Oxybutynin Accord

Dosage Form : TABLETT

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EG SPA

2024 ACI Convention

Not Confirmed

EG SPA

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Oxybutynin hydrochloride

Brand Name : OXYBUTYN EG

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging : 30 UNITS 5 MG - ORAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Lyrinel

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Lyrinel

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Janssen-Cilag AB

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Lyrinel

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Mylan AB

2024 ACI Convention

Not Confirmed

Mylan AB

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Oxybutynin Mylan

Dosage Form : TABLETT

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Nicobrand Limited

Country

2024 ACI Convention

Not Confirmed

Nicobrand Limited

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Kentera

Dosage Form : GEL DOSING PUMP

Dosage Strength : 90.7 MG / G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Nicobrand Limited

Country

2024 ACI Convention

Not Confirmed

Nicobrand Limited

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Sweden

oxibutyninhydroklorid

Brand Name : Kentera

Dosage Form : GEL IN SACHET

Dosage Strength : 90.7 MG / G

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?